Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Academic Clinical Program, Duke-NUS Medical School, National University of Singapore, Singapore.
Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; SERI-NTU Advanced Ocular Engineering (STANCE), Singapore, Singapore.
Prog Retin Eye Res. 2024 Nov;103:101292. doi: 10.1016/j.preteyeres.2024.101292. Epub 2024 Aug 30.
Optical coherence tomography angiography (OCTA) has transformed ocular vascular imaging, revealing microvascular changes linked to various systemic diseases. This review explores its applications in diabetes, hypertension, cardiovascular diseases, and neurodegenerative diseases. While OCTA provides a valuable window into the body's microvasculature, interpreting the findings can be complex. Additionally, challenges exist due to the relative non-specificity of its findings where changes observed in OCTA might not be unique to a specific disease, variations between OCTA machines, the lack of a standardized normative database for comparison, and potential image artifacts. Despite these limitations, OCTA holds immense potential for the future. The review highlights promising advancements like quantitative analysis of OCTA images, integration of artificial intelligence for faster and more accurate interpretation, and multi-modal imaging combining OCTA with other techniques for a more comprehensive characterization of the ocular vasculature. Furthermore, OCTA's potential future role in personalized medicine, enabling tailored treatment plans based on individual OCTA findings, community screening programs for early disease detection, and longitudinal studies tracking disease progression over time is also discussed. In conclusion, OCTA presents a significant opportunity to improve our understanding and management of systemic diseases. Addressing current limitations and pursuing these exciting future directions can solidify OCTA as an indispensable tool for diagnosis, monitoring disease progression, and potentially guiding treatment decisions across various systemic health conditions.
光学相干断层扫描血管造影术 (OCTA) 改变了眼部血管成像,揭示了与各种系统性疾病相关的微血管变化。本文探讨了其在糖尿病、高血压、心血管疾病和神经退行性疾病中的应用。虽然 OCTA 为我们了解身体的微血管提供了宝贵的窗口,但解释其结果可能很复杂。此外,由于其结果相对非特异性,存在一些挑战,即 OCTA 中观察到的变化可能不是特定疾病所特有的,不同 OCTA 机器之间存在差异,缺乏标准化的规范数据库进行比较,以及潜在的图像伪影。尽管存在这些局限性,OCTA 仍具有广阔的应用前景。本文重点介绍了一些有前途的进展,如 OCTA 图像的定量分析、人工智能的集成以实现更快和更准确的解释,以及多模态成像,将 OCTA 与其他技术相结合,以更全面地描述眼部血管。此外,还讨论了 OCTA 在个性化医学中的潜在未来作用,能够根据个体 OCTA 结果制定量身定制的治疗计划、社区筛查计划以早期发现疾病以及跟踪疾病随时间进展的纵向研究。总之,OCTA 为我们改善对系统性疾病的理解和管理提供了重要机会。解决当前的局限性并追求这些令人兴奋的未来方向,可以使 OCTA 成为诊断、监测疾病进展以及在各种系统性健康状况下指导治疗决策的不可或缺的工具。